|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.550 -0.020 (-0.778%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 2.142% | 2.583% | -0.622% | 3.530% | 7.558% |
| ROAE (%) | 4.772% | 6.584% | -1.702% | 8.714% | 16.999% |
| Return on Capital Employed (%) | 3.069% | 4.097% | -0.881% | 5.274% | 10.187% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 68.438% | 69.220% | 65.319% | 72.037% | 76.742% |
| EBITDA Margin (%) | 31.897% | 28.810% | 15.464% | 31.860% | 35.984% |
| Pre-tax Profit Margin (%) | 11.397% | 11.197% | -1.434% | 17.008% | 25.699% |
| Net Profit Margin (%) | 8.670% | 10.111% | -2.584% | 12.755% | 21.960% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.315 X | 1.137 X | 1.418 X | 1.378 X | 1.670 X |
| Quick Ratio (X) | 1.214 X | 1.055 X | 1.317 X | 1.294 X | 1.562 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 46.928% | 54.466% | 59.641% | 60.743% | 54.037% |
| Total Debt / Total Assets (%) | 33.047% | 37.545% | 42.028% | 48.382% | -- |
| Net Debt / Total Assets (%) | 20.341% | 27.962% | 31.231% | 29.646% | -- |
| Total Debt / Shareholders' Funds (%) | 69.362% | 89.471% | 115.802% | 131.356% | -- |
| Long Term Debt / Shareholders' Funds (%) | 26.581% | 22.256% | 51.583% | 57.096% | -- |
| Net Debt / Shareholders' Funds (%) | 42.693% | 66.635% | 86.051% | 80.488% | -- |
| Net Cash / (Debt) ($) | (5.185B) | (6.781B) | (7.053B) | (6.116B) | -- |
| Net Cash / (Debt) per share ($) | (1.378) | (1.910) | (1.991) | (1.882) | -- |
| Total Debt / Capital Employed (%) | 48.545% | 61.674% | 62.227% | 74.508% | -- |
| Interest Coverage Ratio (X) | 2.036 X | 2.420 X | 0.813 X | 3.222 X | 6.530 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 150.676 Day | 150.596 Day | 137.485 Day | 144.852 Day | -- |
| Receivables Turnover (Day) | 123.074 Day | 108.273 Day | 116.450 Day | 107.103 Day | -- |
| Payables Turnover (Day) | 39.427 Day | 34.502 Day | 37.065 Day | 27.222 Day | -- |
| Remarks: | Real time quote last updated: 28/11/2024 16:45 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 387,836 |
| %Change | 158.597% |
| EPS / (LPS) | RMB 0.103 |
| NBV Per Share (¥) | RMB 3.461 |